-
Product Insights
Likelihood of Approval Analysis for Diabetic Macular Edema
Overview How likely is it that the drugs in Diabetic Macular Edema will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Diabetic Macular Edema Overview Diabetic macular edema (DME) occurs when blood...
-
Product Insights
Likelihood of Approval Analysis for Atypical Hemolytic Uremic Syndrome (Nondiarrhea – Associated Hemolytic Uremic Syndrome)
Overview How likely is it that the drugs in Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Atypical Hemolytic Uremic Syndrome...
-
Product Insights
Likelihood of Approval Analysis for Cholestasis
Overview How likely is it that the drugs in Cholestasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cholestasis Overview Cholestasis is the slowing or stalling of bile flow from liver....
-
Product Insights
Likelihood of Approval Analysis for Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease)
Overview How likely is it that the drugs in Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease)...
-
Product Insights
Likelihood of Approval Analysis for Pulmonary Embolism
Overview How likely is it that the drugs in Pulmonary Embolism will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pulmonary Embolism Overview Pulmonary embolism is the sudden blockage of a major...
-
Product Insights
Likelihood of Approval Analysis for Kidney Transplant Rejection
Overview How likely is it that the drugs in Kidney Transplant Rejection will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Kidney Transplant Rejection Overview Kidney transplantation is a therapy performed to...
-
Product Insights
Likelihood of Approval Analysis for Macular Edema
Overview How likely is it that the drugs in Macular Edema will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Macular Edema Overview Macular edema is swelling or fluid retention in a...
-
Product Insights
Likelihood of Approval Analysis for Wet (Neovascular / Exudative) Macular Degeneration
Overview How likely is it that the drugs in Wet (Neovascular / Exudative) Macular Degeneration will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Wet (Neovascular / Exudative) Macular Degeneration Overview Wet...
-
Product Insights
Likelihood of Approval Analysis for Acute Ischemic Stroke
Overview How likely is it that the drugs in Acute Ischemic Stroke will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Ischemic Stroke Overview An acute ischemic stroke occurs when a...
-
Product Insights
Likelihood of Approval Analysis for Cerebrovascular Disease
Overview How likely is it that the drugs in Cerebrovascular Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cerebrovascular Disease Overview Cerebrovascular disease refers to a group of conditions that...